Standout Papers

Challenges and Opportunities in Cancer Drug Resistance 2020 2026 2022 2024306
  1. Challenges and Opportunities in Cancer Drug Resistance (2020)
    Richard A. Ward, Stephen E. Fawell et al. Chemical Reviews

Immediate Impact

4 from Science/Nature 52 standout
Sub-graph 1 of 24

Citing Papers

In-situ-sprayed therapeutic hydrogel for oxygen-actuated Janus regulation of postsurgical tumor recurrence/metastasis and wound healing
2024 Standout
Targeting ROS in cancer: rationale and strategies
2024 Standout
2 intermediate papers

Works of Vikki Flemington being referenced

Targeting melanoma’s MCL1 bias unleashes the apoptotic potential of BRAF and ERK1/2 pathway inhibitors
2019

Author Peers

Author Last Decade Papers Cites
Vikki Flemington 321 12 27 102 101 9 512
Céline Bouclier 250 10 39 86 104 14 497
Sabina Y. van der Zanden 285 8 54 156 53 17 564
Xuan Qin 350 9 9 126 77 24 469
Luwei Liu 299 8 36 111 34 11 479
Alexander R. Chait 294 30 32 102 32 7 480
Ann Palladino 341 12 39 106 32 5 499
Marie Suggitt 195 9 12 145 114 9 421
Mohamed Muhsin 214 17 11 256 102 6 519
Fiona H. Tan 295 19 25 146 64 17 572
Xiuhua Wu 229 11 28 77 46 11 434

All Works

Loading papers...

Rankless by CCL
2026